About Celadon Pharmaceuticals
Celadon Pharmaceuticals is a company based in London (United Kingdom) founded in 2018. Celadon Pharmaceuticals offers products and services including GMP Cannabis API and Cannabis-based Medicines. Celadon Pharmaceuticals operates in a competitive market with competitors including Ergomed and TTS Pharma, among others.
- Headquarter London, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Celadon Pharmaceuticals Plc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.51 M (USD), Post-IPO
Dec 11, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celadon Pharmaceuticals
Celadon Pharmaceuticals offers a comprehensive portfolio of products and services, including GMP Cannabis API and Cannabis-based Medicines.
Extracted active ingredient for cannabis-based medicines
Treatments for chronic pain and neurological conditions
Funding Insights of Celadon Pharmaceuticals
Investments & Acquisitions by Celadon Pharmaceuticals
Investment portfolio details for Celadon Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celadon Pharmaceuticals
Detailed financials for Celadon Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celadon Pharmaceuticals Comparisons
Peer comparison for Celadon Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celadon Pharmaceuticals
Celadon Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ergomed and TTS Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Full-service CRO operations are focused on oncology and complex trials.
|
|
| Locked | Locked | Locked |
TTS Pharma is engaged in producing high-quality, safe Cannabinoid products.
|
Detailed competitors of Celadon Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celadon Pharmaceuticals
Complete news archive for Celadon Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celadon Pharmaceuticals
Celadon Pharmaceuticals was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Celadon Pharmaceuticals is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Celadon Pharmaceuticals was founded in 2018 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, with services centered on clinical trials for cannabis-based products. Support is offered to clients through trial management, regulatory compliance, and data analysis. The company serves the growing cannabis research market, ensuring adherence to UK and international standards for drug development.
Celadon Pharmaceuticals's top competitors include TTS Pharma and Ergomed.
Celadon Pharmaceuticals offers GMP Cannabis API and Cannabis-based Medicines.